GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...

Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

The drug tested was Rybelsus, a pill approved only for type 2 diabetes. Like Novo's blockbusters Ozempic and Wegovy, it ...

What if the race to get thin was quietly putting health at risk? That question is becoming harder to ignore as glucagon‑like ...

Semaglutide shows potential for weight loss in older adults without harming bone density, but longer studies are essential to ...

FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in the ...

Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...

Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials testing whether the medicine can slow cognitive decline in Alzheimer's patients ...

While Ozempic has gained global popularity for treating type-2 diabetes and consequently triggering weight loss, many are now ...

How Much Does Semaglutide Cost? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. You’ve probably heard of ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...